FRAMINGHAM, Mass.--(BUSINESS WIRE)--
Medical care is expected to become more personalized and better able to help prevent the onset of diseases in the future, thanks to groundbreaking research into P4 medicine underway by world-renowned scientists at the Institute for Systems Biology, including National Medal of Science award winner Leroy Hood, MD, PhD., and ISB proteomics research director, Robert Moritz, PhD., and now supported by a new collaboration with AB SCIEX, a global leader in analytical technology.
ISB and AB SCIEX have signed a multi-year agreement to collaborate on the development of methods and technology in proteomics mass spectrometry with the goal to redefine biomarker research and complement genomics through fully comprehensive quantitative proteomics analysis. This will help advance the development of a new approach to medical care.
ISB’s concept of P4 medicine promises to provide deep insight into disease mechanisms on the path to develop medical care that is predictive, personalized, preventive and participatory (the four “P”s) – a pioneering vision that requires a combination of analytical tools, workflows, databases, collaborations and computational strategies.
“With breakthroughs in translating research into clinical relevance, P4 medicine is expected to enable the creation of a virtual cloud of billions of data points around each individual as the basis for straightforward predictions about health and disease,” said Dr. Hood, ISB president and co-founder. In December, he was named a recipient of the National Medal of Science, which is the highest honor the President of the United States can bestow on a scientist, in recognition of visionary work for the advancement of science.
Led by Dr. Hood, ISB’s groundbreaking research is being accelerated by SWATH™ Acquisition, a data-independent acquisition (DIA) mass spectrometry workflow that can quantify virtually all detectable peptides and proteins in a complex sample – all in a single analysis.
“Quantifying enormous numbers of protein analytes at the same time is a critical need to accelerate P4 medicine and the democratization of proteomics, a revolution that is akin to the sequencing of the genome and the democratization of DNA,” added Dr. Hood. “SWATH is a game-changing technique that essentially acts as a protein microarray and is the most reproducible way to generate comprehensive quantitation of the entire proteome. It generates a digital record of the entire proteome that can be mined retrospectively for years to come.”
ISB’s know-how in systems biology and informatics will support the development of SWATH libraries, similar to its highly regarded SRMAtlas project for the human proteome, pioneered by Rob Moritz and his collaborators, and the proteomes of other clinically-relevant organisms. “With complete proteome-wide libraries, ISB provides the basis to support comprehensive SWATH analysis,” said Dr. Moritz, ISB Proteomics Research Director.
Committed to an open policy of sharing data and methods, ISB will make the SWATH libraries available to the global scientific community to accelerate the use of SWATH for other biological research. Utilizing the depth in proteomics technology development and underpinned by the extensive proteomics computational resources in data interpretation tools, standards initiatives and database development under the leadership of Dr. Moritz, ISB will develop new SWATH technologies and tools to enable the community to quickly adopt comprehensive quantitative proteome analysis.
“Having the proteomics data standardized across laboratories and across samples really enables us to quantitate entire proteomes at a level that hasn’t been done before,” said Dr. Moritz. “We aim to define markers that can predict whether a patient will respond to a certain treatment or not, and applying SWATH will play a big part in taking our advancements to another level. Not only can we now complement the breadth of genomics, but we will have the much-needed libraries and software development going forward to make data-sharing quite easier and standardized.”
As a trusted partner with academic researchers, AB SCIEX has formed this strategic alliance with Dr. Hood, Dr. Moritz and their distinguished ISB colleagues through the AB SCIEX Academic Partnership Program to help broaden the availability of new technologies to researchers delving into omics research around the world.
“What ISB does with SWATH will set a new benchmark in proteomics research,” said Rainer Blair, President of AB SCIEX. “Our collaboration with ISB will help drive SWATH into the mainstream of analytical science and make comprehensive, reproducible and simplified omics data more accessible to biologists around the world.”
ISB will be using the AB SCIEX TripleTOF® 5600± System and an Eksigent ekspert™ nano-LC 400 System as the instrument platforms on which to conduct the protein identification and quantitation. The TripleTOF 5600+ System provides the high speed necessary for SWATH Acquisition. TripleTOF technology combines high speed and high sensitivity with high resolution and accurate mass. ISB also plans to use SelexION™ technology, a recent advancement in differential ion mobility, in the future to advance its research.
About P4 Medicine
P4 Medicine – i.e. medicine that is Predictive, Preventive, Personalized and Participatory -- is emerging out of the convergence of systems biology, the increasing activation of networked consumers and the digital revolution in communications and information technology. Historically, human biology was a black box about which little was known apart from surface manifestations of disease. That black box is now being opened by systems biology. P4 medicine looks inside that black box for each individual using the pioneering capability of systems biology to generate actionable understandings of disease and wellness as a continuum of network states unique in time and space to each individual human being.
About the Institute for Systems Biology
The Institute for Systems Biology (ISB) is a world-renowned, non-profit research institute headquartered in Seattle that is dedicated to the study and application of systems biology. Founded in 2000, ISB seeks to unravel the mysteries of biology while identifying strategies for predicting and preventing diseases, solving energy and environmental issues, and improving K-12 science education. ISB's systems approach integrates biology, computation and technological development, enabling scientists to analyze all elements in a biological system rather than one gene or protein at a time. ISB has 10 faculty members and about 230 staff. Visit ISB at www.systemsbiology.org or on Twitter @ISBUSA and Facebook.
About AB SCIEX
AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company’s global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 25 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information about the company, go to www.absciex.com. Follow AB SCIEX on Twitter @ABSCIEX, Facebook and LinkedIn.
© 2013. AB SCIEX. AB Sciex Instruments Are For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.
- Science, Social Science, & Humanities
Recommended for You
* Facebook said to conceal mobile usage impact on revenue * Facebook says lawsuit without merit * Sandberg, Morgan Stanley, others were also sued NEW YORK, Dec 18 (Reuters) - Facebook Inc, Chief Executive Mark Zuckerberg and dozens of banks must face a lawsuit accusing the social media company…Reuters
Mobile burst onto the scene before anyone had a tight grasp on what it meant for marketing, let alone commerce, social interaction, travel, communication, learning—the list goes on. Mobile statistics are staggering: 91 percent of all adults on earth own a mobile phone, 56 percent…Business 2 Community
The Federal Reserve said Wednesday it would start to taper its bond-buying program to $75 billion a month.CNBC
Nearly all the major insurers have agreed to cover their customers retroactively if they go to the emergency room or doctor’s office after Jan. 1, but send in their payment by Jan. 10.The New York Times
CNBC's Dominic Chu reports retailer Target has been hit by theft of customer's credit card data over the Black Friday weekend. Dow Jones reports the breach is extensive and may be tied to malware.CNBC
Ford Motor Co., a darling of the auto industry's comeback, is facing its biggest test since CEO Alan Mulally charted its successful course out of the Great Recession. The company outlined its challenges ...Associated Press
Lottery officials say a Georgia woman has one of the two winning tickets to the $636 million Mega Millions jackpot, the second-largest in U.S. history. (Dec. 18)Associated Press Videos
It's been a year since Joe Hinrichs took over as head of Ford Motor Co.'s Americas division, the latest step in a journey many think could eventually lead to the CEO's office. Hinrichs, 46, got the job ...Associated Press
As many of you already know, the gross domestic product (GDP) estimate for the third quarter came in above estimates at 3.6%, with most of the increase coming from higher inventory levels. But I would like to look at something slightly different than the inventory buildup. I think we are all aware…Business 2 Community
Monumental industry changes mean there are lots of misconceptions about buying a home. They could cost you big when it comes time to go house hunting.Credit.com
BP Plc said the Gila prospect in the Gulf of Mexico produced a “significant” discovery, capping the most successful year for exploration since 2004 for Europe’s second-biggest oil company.Bloomberg
Boeing Co (BA) on Wednesday promoted Dennis Muilenburg, head of its defense division, to the post of president and chief operating officer, a move that company insiders and analysts said makes him "heir apparent" to Chief Executive Jim McNerney. Muilenburg, 49, and Ray Conner, the 58-year old head…Reuters
TheStreet's Jim Cramer and Stephanie Link say shares of Johnson Controls present a 'big time buying opportunity' right now. Link says the newly appointed CEO, Alex Molinaroli, is moving the company into higher growth, higher margin businesses.TheStreet.com Videos
Jay Morgan says the remarks about an advanced training facility in LouisvilleUSA TODAY
We're a mere weeks from 2014, and here's a sign of the times: a 3D printing company has just picked up a piece of Xerox, a name that's still a bit hard for many to divorce from images of ...Engadget
Would you buy a car from the same company that made your phone? Rumors of an Apple "iCar" have circulated for some time now, though they're largely viewed as not credible--and now similar rumors might be directed toward Samsung. The Korean electronics giant recently filed a series of patents for…Green Car Reports
NEW YORK (MarketWatch) -- Shares in AMC Entertainment Holdings Inc. are poised to start trading Wednesday on the New York Stock Exchange after the movie-theater chain priced its initial public offering ...MarketWatch
CNBC's Josh Lipton and CNET Editor-in-Chief Lindsey Turrentine talk about Apple's new Mac Pro and LG's forthcoming Chromebase desktop computer.CNBC Videos